New first-in-class drug for the treatment of ER+ MBC
Article by Dr. Angela Alexander On Apr 30th, the FDA approved a new first-in-class drug for the treatment of ER+ metastatic breast cancer (MBC). The new drug Vepdegestrant was approved only for patients with tumors that harbor ESR1 mutations, based on results from...
New Diagnosis Codes for IBC Are Here—Now the Real Work Begins
On October 1, 2025, a long-overdue change will take effect: Inflammatory Breast Cancer (IBC) will finally have its own diagnosis codes—C50.A0, C50.A1, and C50.A2. This change will improve how IBC is documented, tracked, and treated. It will help patients begin...
My Social Security Story
My name is Olivia, and on November 30, 2020, at 27 years old, I was diagnosed with HER2+ stage 4 inflammatory breast cancer (IBC) with bone metastasis—just after having my baby boy. Soon after starting treatment, I learned that IBC qualifies for Social Security...
Your voice is crucial.
I receive messages like this every single day, and it breaks my heart. Often, we—along with well-meaning doctors—search for reasonable explanations for why a breast is swollen, even if our intentions aren’t harmful. For cat owners, it’s not uncommon to get scratched....